Rising use of GLP-1 weight loss drugs among kids and new findings linking them to increased testosterone in men highlight growing medical and societal impacts.
Bumble's relationship guru Shan Boodram dropped by TODAY to chat with Jenna Bush Hager and Ciara about how to "manifest love" in the modern dating world. The key takeaways? Stay open to possibilities, don’t be afraid to make the first move, and put yourself out there—because love won’t knock if you’re hiding behind a "Do Not Disturb" sign.
Editor’s Note: Dating apps have changed the game, but the basics still apply—confidence and openness go a long way. With Valentine’s Day vibes lingering and cuffing season in full swing, this segment taps into that universal itch to find connection (or at least swipe smarter). It’s a pep talk for anyone feeling stuck in dating limbo, wrapped in the cozy authority of a celebrity-backed advice session.
CVS Health just scored a big win by landing a pharmacy benefits contract with Calpers, California’s massive public employee retirement system. They beat out rival UnitedHealth for the deal, which means CVS’s Caremark division will now manage prescription drug coverage for hundreds of thousands of state workers and retirees.
Editor’s Note: This isn’t just another corporate contract—it’s a major shift in who controls prescription benefits for a huge chunk of California’s workforce. Calpers is one of the biggest public pension funds in the U.S., so this deal solidifies CVS’s grip on the pharmacy benefits market while dealing a blow to UnitedHealth’s ambitions in the space. For everyday folks, it could mean changes in how they access medications, depending on how CVS structures the plan. Bottom line: It’s a power move in the ongoing battle over who gets to manage America’s prescription drug spending.
The use of GLP-1 weight loss drugs in kids has exploded—up 65% right after the American Academy of Pediatrics gave them the green light in early 2023, and the trend hasn’t slowed down. NBC’s Kate Snow digs into which ages might actually benefit from these medications and what experts are saying about the surge.
Editor’s Note: This isn’t just another headline about weight loss drugs—it’s about how quickly they’re being adopted for kids, raising big questions. Are they safe long-term for developing bodies? Who really needs them? The spike in prescriptions suggests parents and doctors are eager for solutions, but the debate over risks and ethics is just heating up.
A federal judge just struck down a Biden administration rule that aimed to prevent medical debt from dragging down Americans' credit scores. This means unpaid hospital bills and other medical debts can still show up on credit reports, potentially making it harder for people to get loans, rent apartments, or even land jobs.
Editor’s Note: For millions of Americans, medical debt isn't just a bill—it's a long-term financial anchor. This ruling keeps the pressure on, since credit scores shape so much of daily life. It’s a setback for efforts to ease the burden of healthcare costs, especially when surprise bills or emergencies can tank someone’s financial stability overnight.
Jennifer Romolini, a former workaholic turned author and podcaster, shares her personal tips for finding joy and balance in Los Angeles. In her new podcast, Extended Scenes, she talks about her favorite spots in the city that help her stay grounded—even when the world feels like it's falling apart. Think of it as a survival guide for modern life, with a sunny L.A. twist.
Editor’s Note: Let’s face it—life can feel overwhelming, especially in a fast-paced city like L.A. Romolini’s take isn’t just about self-care clichés; it’s a relatable, real-talk approach to staying sane when everything else feels chaotic. Whether you’re local or just curious, her insights offer a refreshing perspective on carving out little moments of peace.
This piece is a quick rundown of recent chatter in the health care sector, spotlighting companies like Waters Corp. and Becton Dickinson. Think of it as a snapshot of what investors and analysts are buzzing about—whether it's earnings, innovations, or market moves—without diving too deep into any single topic.